TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

NCT02043847 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma, Relapsed
Multiple Myeloma, Refractory to Standard Treatment

Interventions

RADIATION: Total Marrow Irradiation
DRUG: Melphalan
DRUG: Filgrastim (G-CSF)
PROCEDURE: Autologous transplant
RADIATION: Total Marrow Irradiation
DRUG: Melphalan
DRUG: Filgrastim (G-CSF)
PROCEDURE: Autologous transplant
RADIATION: Total Marrow Irradiation
DRUG: Melphalan
DRUG: Filgrastim (G-CSF)
PROCEDURE: Autologous transplant

Sponsor

University of Illinois at Chicago